These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30852434)

  • 1. A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore.
    Abdin E; Chong SA; Seow E; Peh CX; Tan JH; Liu J; Hui SFS; Chua BY; Sim K; Verma S; Vaingankar JA; Subramaniam M
    Psychiatry Res; 2019 Apr; 274():400-408. PubMed ID: 30852434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the schizophrenia quality of life scale to EQ-5D, HUI3 and SF-6D utility scores in patients with schizophrenia.
    Seow LSE; Lau JH; Abdin E; Verma SK; Tan KB; Subramaniam M
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):813-821. PubMed ID: 37216213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia.
    Abdin E; Chong SA; Seow E; Verma S; Tan KB; Subramaniam M
    Qual Life Res; 2019 Jan; 28(1):177-186. PubMed ID: 30382480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia.
    Luo N; Seng BK; Thumboo J; Feeny D; Li SC
    Qual Life Res; 2006 Jun; 15(5):889-98. PubMed ID: 16721648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the Burden of Schizophrenia Using Clinician and Patient-Reported Measures: An Exploratory Analysis of Construct Validity.
    Franklin M; Mukuria C; Mulhern B; Tran I; Brazier J; Watson S
    Patient; 2019 Aug; 12(4):405-417. PubMed ID: 30820841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression.
    Abdin E; Chong SA; Seow E; Tan KB; Subramaniam M
    BMC Psychiatry; 2021 Sep; 21(1):451. PubMed ID: 34517871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
    Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
    Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease.
    Luo N; Chew LH; Fong KY; Koh DR; Ng SC; Yoon KH; Vasoo S; Li SC; Thumboo J
    J Rheumatol; 2003 Oct; 30(10):2268-74. PubMed ID: 14528528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing disease-specific and generic quality of life measures in patients with schizophrenia.
    Seow LSE; Tan THG; Abdin E; Chong SA; Subramaniam M
    Psychiatry Res; 2019 Mar; 273():387-393. PubMed ID: 30682561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability and validity of the Disabilities of Arm, Shoulder, and Hand, EuroQol-5D, Health Utilities Index, and Short Form-6D outcome instruments in patients with proximal humeral fractures.
    Slobogean GP; Noonan VK; O'Brien PJ
    J Shoulder Elbow Surg; 2010 Apr; 19(3):342-8. PubMed ID: 20189839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EQ-5D in skin conditions: an assessment of validity and responsiveness.
    Yang Y; Brazier J; Longworth L
    Eur J Health Econ; 2015 Dec; 16(9):927-39. PubMed ID: 25358263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression.
    Dickerson JF; Feeny DH; Clarke GN; MacMillan AL; Lynch FL
    Qual Life Res; 2018 Feb; 27(2):447-454. PubMed ID: 29149441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric properties of the short Warwick Edinburgh mental well-being scale (SWEMWBS) in service users with schizophrenia, depression and anxiety spectrum disorders.
    Vaingankar JA; Abdin E; Chong SA; Sambasivam R; Seow E; Jeyagurunathan A; Picco L; Stewart-Brown S; Subramaniam M
    Health Qual Life Outcomes; 2017 Aug; 15(1):153. PubMed ID: 28764770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D.
    Mulhern B; Mukuria C; Barkham M; Knapp M; Byford S; Soeteman D; Brazier J
    Br J Psychiatry; 2014 Sep; 205(3):236-43. PubMed ID: 24855127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.